Why Doximity Shares Fell Today | Quiver Quantitative

Doximity (DOCS) is down 5.6% today. Here is some analysis on what might have caused this price movement.

Analysis: The most likely driver is investor caution ahead of Doximity’s fiscal first-quarter 2027 results, which were scheduled for release after the market close on August 6. This could also reflect lingering concern from the company’s prior outlook, which pointed to only modest revenue growth and lower adjusted profitability as spending on AI and related initiatives increased.

Details:

Doximity said it would report fiscal first-quarter 2027 results after market close on August 6 and host a webcast later that afternoon, putting the stock in focus for an event-driven move.

In its May results, the company guided for fiscal first-quarter revenue of $151 million to $152 million and adjusted EBITDA of $68.5 million to $69.5 million.

Doximity’s full-year fiscal 2027 guidance called for revenue of $664 million to $676 million and adjusted EBITDA of $323 million to $335 million, signaling slower profit growth than some investors had grown used to.

Its most recently reported quarter showed revenue rising 5% year over year to $145.4 million, while net income fell sharply and research and development expense climbed, reinforcing concerns about margin pressure.

Sources:

Doximity, SEC, Stock Analysis

Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

$DOCS Insider Trading Activity

$DOCS insiders have traded $DOCS stock on the open market 7 times in the past 6 months. Of those trades, 0 have been purchases and 7 have been sales.

Here’s a breakdown of recent trading of $DOCS stock by insiders over the last 6 months:

SIDDHARTH SITARAM (Chief Accounting Officer) has made 0 purchases and 6 sales selling 13,513 shares for an estimated $321,164.
KIRA SCHERER WAMPLER sold 2,000 shares for an estimated $52,000

To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.

$DOCS Hedge Fund Activity

We have seen 186 institutional investors add shares of $DOCS stock to their portfolio, and 266 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

CAPITAL WORLD INVESTORS removed 3,224,196 shares (-57.0%) from their portfolio in Q1 2026, for an estimated $75,123,766
BAILLIE GIFFORD & CO removed 3,067,665 shares (-82.7%) from their portfolio in Q2 2026, for an estimated $63,623,372
WELLINGTON MANAGEMENT GROUP LLP added 2,494,670 shares (+13144.4%) to their portfolio in Q1 2026, for an estimated $58,125,811
CARMIGNAC GESTION added 2,418,971 shares (+127.8%) to their portfolio in Q1 2026, for an estimated $56,362,024
VOYA INVESTMENT MANAGEMENT LLC removed 1,761,839 shares (-92.3%) from their portfolio in Q1 2026, for an estimated $41,050,848
CITADEL ADVISORS LLC removed 1,669,545 shares (-68.6%) from their portfolio in Q1 2026, for an estimated $38,900,398
DEUTSCHE BANK AG\ added 1,408,091 shares (+93.0%) to their portfolio in Q1 2026, for an estimated $32,808,520

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

$DOCS Government Contracts

We have seen $175,680 of award payments to $DOCS over the last year.

Here are some of the awards which we have have seen pay out the most over the last year:

AMION ON-CALL SCHEDULE FOR HOSPITAL STAFF: $51,500
AMION FOR ENTERPRISES: $20,705
AMION LICENSES (45) 6-MONTH EXTENSION: $20,000
AMION ENTERPRISE LICENSE SUBSCRIPTION - PALO ALTO VAMC: $17,101
LICENSES: $11,000

To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard. You can access data on government contracts through the Quiver Quantitative API government contracts endpoint.

$DOCS Price Targets

Multiple analysts have issued price targets for $DOCS recently. We have seen 19 analysts offer price targets for $DOCS in the last 6 months, with a median target of $25.0.

Here are some recent targets:

Allen Lutz from B of A Securities set a target price of $20.0 on 06/29/2026
David Roman from Goldman Sachs set a target price of $24.0 on 05/15/2026
Glen Santangelo from Barclays set a target price of $20.0 on 05/15/2026
Jailendra Singh from Truist Securities set a target price of $19.0 on 05/14/2026
Richard Close from Canaccord Genuity set a target price of $30.0 on 05/14/2026
Brian Tanquilut from Jefferies set a target price of $19.0 on 05/14/2026
Alexei Gogolev from JP Morgan set a target price of $28.0 on 05/14/2026

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.